Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.
Press releases published on September 24, 2025
Newsmatics Brings AI-Powered News Platforms to Czech Republic’s AI Festival for Everyone
Executives and staff showcased its suite of AI-driven tools and platforms at the event WASHINGTON , DC, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- Artificial intelligence has become woven into everyday activities at home and at work, and it …
Range Impact Announces $550,000 Capital Raise
Cleveland, Ohio, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, announced the closing of …
Verano to Report Third Quarter 2025 Financial Results on October 29, 2025
CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the third quarter ended …
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a …
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that …
uniQure Announces $200 Million Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200 million …
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadership …
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its …
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
IRVINE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., President and Chief Scientific Officer, will participate in a plenary session at the upcoming 18th Congress …
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced a proposed underwritten public offering of shares of its Class A common stock …
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
NEW HAVEN, Conn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ: IVVD) today announced the appointment of Paul B. Bolno, M.D., to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President and CEO of Wave …
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
- 86% overall survival (OS) observed at 9 months; standard of care benchmark is ~47% - - 53% progression-free survival (PFS) observed at 9 months; standard of care benchmark is ~29% - - Company expects regulatory feedback on pivotal trial plans in Q4 2025 …
Inventiva to Host Analyst and Investor Event on October 8, 2025
Program will include an update on the Company’s lead asset, lanifibranor, ahead of anticipated Phase 3 NATiV3 topline results in the second half of 2026 Three renowned international experts and a patient representative will highlight key trends shaping the …
Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
Le programme inclura une mise à jour sur son médicament candidat, lanifibranor, en amont des résultats principaux de l’étude de Phase 3 NATiV3 attendus au second semestre 2026 Trois experts internationaux de renom et un représentant des patients mettront …
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
LOS ANGELES, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced that two of Southern California’s most accomplished life sciences executives -- Murthy Simhambhatla, PhD, President …
New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Business Collaborative for Brain Health (BCBH), led by UsAgainstAlzheimer’s, has released a new report outlining strategic recommendations for global business and policy leaders to invest in brain capital—a …
Unity Consortium Announces Bold Commitment to Empower Teen Vaccine Ambassadors at Clinton Global Initiative Meeting
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Unity Consortium today announced the launch of its new Trusted Teen CommUNITY program. This ambitious initiative seeks to educate and mobilize 10,000 Teen CommUNITY Leaders (TCLs) across the country to serve as …
Global Neuroprotection Devices Market to Register Growth at a CAGR of ~7% by 2032 | DelveInsight
New York, USA, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Global Neuroprotection Devices Market to Register Growth at a CAGR of ~7% by 2032 | DelveInsight The neuroprotection devices market is experiencing growth due to the rising incidence of cardiovascular and …
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
H1 2025 results Activity and profitability H1 revenue: €387.8 million, down 5.4% at CER1 and on a like-for-like basis2, mainly due to the decline in activity in France Restated EBITDA margin3 came out at 12.9%, compared with 15.4% a year earlier 2025 …
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC et périmètre comparable principalement en lien avec la baisse d’activité en France
Résultats semestriels 2025 Activité et rentabilité Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC1 et périmètre comparable2, principalement en lien avec la baisse d’activité en France La marge d’EBITDA retraité3 ressort à …